BridgeBio Pharma (BBIO) Net Income Growth (1y) (2019 - 2026)
BridgeBio Pharma (BBIO) Net Income Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - | - |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn | 63.48% |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 1,228.66% |
| 10 | BridgeBio Pharma | 16.78 Bn | 15.84 Bn | 184.58 Mn | 1.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.83% |
| Dec 31, 2025 | 27.23% |
| Sep 30, 2025 | -12.59% |
| Jun 30, 2025 | -143.25% |
| Mar 31, 2025 | -249.30% |
| Dec 31, 2024 | -32.17% |
| Sep 30, 2024 | 5.71% |
| Jun 30, 2024 | 54.66% |
| Mar 31, 2024 | 76.34% |
| Dec 31, 2023 | -28.04% |
| Sep 30, 2023 | -18.89% |
| Jun 30, 2023 | -65.79% |
| Mar 31, 2023 | 23.87% |
| Dec 31, 2022 | 15.99% |
| Sep 30, 2022 | 16.06% |
| Jun 30, 2022 | 49.63% |
| Mar 31, 2022 | -9.46% |
| Dec 31, 2021 | -37.33% |
| Sep 30, 2021 | 19.62% |
| Jun 30, 2021 | -27.99% |